Shared on04 Aug 25Fair value Increased 19%
The modest increases in both net profit margin and future P/E suggest improved profitability and sustained growth expectations for HealthCare Global Enterprises, supporting the upward revision of the consensus analyst price target from ₹567.29 to ₹603.88. What's in the News KKR Asian Fund IV SCSp, managed by KKR & Co. Inc., and KIA EBT II Scheme 1 completed the acquisition of a 50.4% stake in HealthCare Global Enterprises Limited from Aceso Company Pte Ltd for INR 34.28 billion, with regulatory approvals secured.
Shared on23 Apr 25Fair value Increased 2.12%
AnalystConsensusTarget made no meaningful changes to valuation assumptions.
Shared on09 Apr 25
AnalystConsensusTarget made no meaningful changes to valuation assumptions.
Shared on02 Apr 25Fair value Increased 4.79%
AnalystConsensusTarget made no meaningful changes to valuation assumptions.
Shared on26 Mar 25
AnalystConsensusTarget made no meaningful changes to valuation assumptions.
Shared on19 Mar 25Fair value Decreased 7.59%
AnalystConsensusTarget made no meaningful changes to valuation assumptions.